Generated: December 11, 2017
DrugPatentWatch Database Preview
Escitalopram oxalate - Generic Drug Details
« Back to Dashboard
What are the generic drug sources for escitalopram oxalate and what is the scope of escitalopram oxalate freedom to operate?
is the generic ingredient in two branded drugs marketed by Mylan Pharms Inc, Amneal Pharms, Antrim Pharms Llc, Aurobindo Pharma Ltd, Hetero Labs Ltd Iii, Macleods Pharms Ltd, Silarx Pharms Inc, Taro, Forest Labs, Accord Hlthcare, Apotex Inc, Hikma Pharms, Invagen Pharms, Jubilant Generics, Lupin Ltd, Prinston Inc, Sti Pharma Llc, Teva Pharms Usa, Torrent Pharms Ltd, and Zydus Pharms Usa Inc, and is included in twenty-five NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.
There are twenty-six drug master file entries for escitalopram oxalate. Fifty-nine suppliers are listed for this compound. There are six tentative approvals for this compound.
Summary for escitalopram oxalate
Pharmacology for escitalopram oxalate
Tentative approvals for ESCITALOPRAM OXALATE
|Apotex Inc||ESCITALOPRAM OXALATE||escitalopram oxalate||TABLET;ORAL||078777-003||Sep 11, 2012||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Lupin Ltd||ESCITALOPRAM OXALATE||escitalopram oxalate||TABLET;ORAL||078169-003||Sep 11, 2012||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Jubilant Generics||ESCITALOPRAM OXALATE||escitalopram oxalate||TABLET;ORAL||202280-001||Sep 12, 2012||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Teva Pharms Usa||ESCITALOPRAM OXALATE||escitalopram oxalate||TABLET;ORAL||076765-002||Mar 14, 2012||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Amneal Pharms||ESCITALOPRAM OXALATE||escitalopram oxalate||TABLET;ORAL||205619-003||May 17, 2017||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Hikma Pharms||ESCITALOPRAM OXALATE||escitalopram oxalate||TABLET;ORAL||078766-003||Sep 11, 2012||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Mylan Pharms Inc||ESCITALOPRAM OXALATE||escitalopram oxalate||CAPSULE;ORAL||077660-001||Jul 31, 2007||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Teva Pharms Usa||ESCITALOPRAM OXALATE||escitalopram oxalate||TABLET;ORAL||076765-003||Mar 14, 2012||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Invagen Pharms||ESCITALOPRAM OXALATE||escitalopram oxalate||TABLET;ORAL||078604-002||Sep 11, 2012||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Sti Pharma Llc||ESCITALOPRAM OXALATE||escitalopram oxalate||TABLET;ORAL||077512-003||Sep 12, 2012||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Expired Orange Book Patents for Generic Ingredient: escitalopram oxalate
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.